BCA
NTRP

Bay Colony Advisors’s Neurotrope, Inc. Common NTRP Stock Holding History

Bay Colony Advisors’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-190
Closed -$2K – 987
2018
Q2 		$2K Buy
+190
New +$1.75K ﹤0.01% 882

Other funds holding NTRP

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Bay Colony Advisors's NTRP Position: Q3 2018 in Review

Bay Colony Advisors sold out of Neurotrope, Inc. Common (NTRP) in Q3 2018, closing a stake of 190 shares — an estimated $2K sold.

Bay Colony Advisors first reported a position in NTRP in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 24 funds tracked by Wall St. Rank hold NTRP as of Q3 2018.

  • Bay Colony Advisors reported no remaining Neurotrope, Inc. Common position as of Q3 2018 after selling out during the quarter.
  • Bay Colony Advisors sold 190 Neurotrope, Inc. Common shares in Q3 2018, an estimated $2K.
  • Bay Colony Advisors first reported a position in Neurotrope, Inc. Common in Q2 2018 and held it in 1 quarter.
  • Bay Colony Advisors's Neurotrope, Inc. Common position peaked at $2K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.